These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 37300267)

  • 1. Prevalence, Clinical Characteristics, and Clinical Outcomes of New-onset Diabetes Mellitus among COVID-19 Patients in Developing and Developed Countries: A Systematic Review.
    Junaid K; Dawood N; Daood M; Randhawa FA; Yousaf MK; Ahmad MS
    J Coll Physicians Surg Pak; 2023 Jun; 33(6):691-699. PubMed ID: 37300267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis.
    Bellia C; Andreadi A; D'Ippolito I; Scola L; Barraco S; Meloni M; Lauro D; Bellia A
    Front Endocrinol (Lausanne); 2023; 14():1215879. PubMed ID: 37732118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression.
    Chenchula S; Vidyasagar K; Pathan S; Sharma S; Chavan MR; Bhagavathula AS; Padmavathi R; Manjula M; Chhabra M; Gupta R; Amerneni KC; Ghanta MK; Mudda S
    Sci Rep; 2023 Apr; 13(1):6415. PubMed ID: 37076543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes Mellitus during the Pandemic Covid-19: Prevalence, Pathophysiology, Mechanism, and Management: An updated overview.
    Rais N; Ahmad R; Ved A; Parveen K; Ishrat T; Prakash O; Shadab M; Bari DG; Siddiqui NA
    Curr Diabetes Rev; 2022; 18(3):e120721194712. PubMed ID: 34931983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis.
    Kaminska H; Szarpak L; Kosior D; Wieczorek W; Szarpak A; Al-Jeabory M; Gawel W; Gasecka A; Jaguszewski MJ; Jarosz-Chobot P
    Acta Diabetol; 2021 Aug; 58(8):1101-1110. PubMed ID: 33778910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillosis and Mucormycosis in COVID-19 Patients: A Systematic Review.
    Afzal S; Nasir M
    J Coll Physicians Surg Pak; 2022 May; 32(5):639-645. PubMed ID: 35546702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of COVID-19 with diabetes: a systematic review and meta-analysis.
    Ssentongo P; Zhang Y; Witmer L; Chinchilli VM; Ba DM
    Sci Rep; 2022 Nov; 12(1):20191. PubMed ID: 36418912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related risk factors and severity of SARS-CoV-2 infection: a systematic review and meta-analysis.
    Rahman MM; Bhattacharjee B; Farhana Z; Hamiduzzaman M; Chowdhury MAB; Hossain MS; Siddiqee MH; Islam MZ; Raheem E; Uddin MJ
    J Prev Med Hyg; 2021 Jun; 62(2):E329-E371. PubMed ID: 34604574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis.
    Ghayda RA; Lee J; Lee JY; Kim DK; Lee KH; Hong SH; Han YJ; Kim JS; Yang JW; Kronbichler A; Smith L; Koyanagi A; Jacob L; Shin JI
    Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32668763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, clinical characteristics, and outcomes of pediatric COVID-19: A systematic review and meta-analysis.
    Badal S; Thapa Bajgain K; Badal S; Thapa R; Bajgain BB; Santana MJ
    J Clin Virol; 2021 Feb; 135():104715. PubMed ID: 33348220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic control predicts SARS-CoV-2 prognosis in diabetic subjects.
    Greco C; Pirotti T; Brigante G; Filippini T; Pacchioni C; Trenti T; Simoni M; Santi D
    Acta Diabetol; 2023 Jun; 60(6):817-825. PubMed ID: 36939895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and short-term clinical impacts of new-onset diabetes mellitus among patients with COVID-19 in jazan region, Saudi Arabia.
    Mohamed AH; Darraj M; Yassin A; Somaili M; Sayed A; Oraibi O; Mohrag M; Madkhali MA; Alqassimi S; Madkhali MA
    BMC Endocr Disord; 2024 Sep; 24(1):197. PubMed ID: 39304825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients.
    Palaiodimos L; Chamorro-Pareja N; Karamanis D; Li W; Zavras PD; Chang KM; Mathias P; Kokkinidis DG
    Hormones (Athens); 2021 Jun; 20(2):305-314. PubMed ID: 33123973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the clinical profile, laboratory parameters and outcome of two hundred COVID-19 patients from a tertiary centre in India.
    Gupta N; Ish P; Kumar R; Dev N; Yadav SR; Malhotra N; Agrawal S; Gaind R; Sachdeva H; Covid Working Group OMOTSH
    Monaldi Arch Chest Dis; 2020 Nov; 90(4):. PubMed ID: 33169598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus increases the risk of hospital mortality in patients with Covid-19: Systematic review with meta-analysis.
    Miller LE; Bhattacharyya R; Miller AL
    Medicine (Baltimore); 2020 Oct; 99(40):e22439. PubMed ID: 33019426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of diabetes on COVID-19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta-analysis.
    Kastora S; Patel M; Carter B; Delibegovic M; Myint PK
    Endocrinol Diabetes Metab; 2022 May; 5(3):e00338. PubMed ID: 35441801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-Onset Diabetes Mellitus, Hypertension, Dyslipidaemia as Sequelae of COVID-19 Infection-Systematic Review.
    Wrona M; Skrypnik D
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic Patients with COVID-19 Complications: Insights into Prevalence, Prognosis, Combination Medications, and Underlying Mechanisms.
    Wal P; Dwivedi J; Wal A; Kushwaha S
    Curr Diabetes Rev; 2023; 19(7):e250822208008. PubMed ID: 36028964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes, obesity, hypertension and risk of severe COVID-19: a protocol for systematic review and meta-analysis.
    Li C; Islam N; Gutierrez JP; Lacey B; Moolenaar RL; Richter P
    BMJ Open; 2021 Nov; 11(11):e051711. PubMed ID: 34836901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.